Follow me on Twitter
I agree that content from Twitter will be displayed to me.
Head of Group
Director of Corporate Program
His main research interests are ligand- and structure-based drug design with focus on transmembrane transport proteins, prediction of on- and off-kinetics, as well as semantic data integration.
Publications
Showing entries 1 - 5 out of 314
Magel, V, Blum, J, Dolde, X, Leisner, H, Grillberger, K, Khalidi, H, Gardner, I, Ecker, GF, Pallocca, G, Dreser, N & Leist, M 2024, 'Inhibition of Neural Crest Cell Migration by Strobilurin Fungicides and Other Mitochondrial Toxicants', Cells, vol. 13, no. 24, 2057. https://doi.org/10.3390/cells13242057
Li, E, Boujeddaine, N, Houtman, MJC, Maas, RGC, Sluijter, JPG, Ecker, GF, Stary-Weinzinger, A, van Ham, WB & van der Heyden, MAG 2024, 'Development of new Kir2.1 channel openers from propafenone analogues', British Journal of Pharmacology, vol. 182, no. 3, pp. 633-650. https://doi.org/10.1111/bph.17377
Ortega-Vallbona, R, Palomino-Schätzlein, M, Tolosa, L, Benfenati, E, Ecker, GF, Gozalbes, R & Serrano-Candelas, E 2024, 'Computational Strategies for Assessing Adverse Outcome Pathways: Hepatic Steatosis as a Case Study', International Journal of Molecular Sciences, vol. 25, no. 20, 11154. https://doi.org/10.3390/ijms252011154
Digles, D, Ingles-Prieto, A, Dvorak, V, Mocking, TAM, Goldmann, U, Garofoli, A, Homan, EJ, Di Silvio, A, Azzollini, L, Sassone, F, Fogazza, M, Bärenz, F, Pommereau, A, Zuschlag, Y, Ooms, JF, Tranberg-Jensen, J, Hansen, JS, Stanka, J, Sijben, HJ, Batoulis, H, Bender, E, Martini, R, IJzerman, AP, Sauer, DB, Heitman, LH, Manolova, V, Reinhardt, J, Ehrmann, A, Leippe, P, Ecker, GF, Huber, KVM, Licher, T, Scarabottolo, L, Wiedmer, T & Superti-Furga, G 2024, 'Advancing drug discovery through assay development: a survey of tool compounds within the human solute carrier superfamily', Frontiers in Pharmacology, vol. 15, 1401599. https://doi.org/10.3389/fphar.2024.1401599
Granulo, N, Sosnin, S, Digles, D & Ecker, GF 2024, 'The macrocycle inhibitor landscape of SLC‐transporter', Molecular Informatics, vol. 43, no. 5, e202300287. https://doi.org/10.1002/minf.202300287
Activities
Showing entries 96 - 100 out of 203
Synthesis and biological evaluation of novel carbocycle-containing combretastatin A-4 analogs
Rita Fürst
,
Christina Nowikow
,
Agnes Berenyi
,
Gerhard Ecker
,
Walther Schmid
,
Istvan Zupko
,
Uwe Rinner
240th American Chemical Society National Meeting & Exposition
Conference,
Poster presentation
..2010 - ..2010
Synthesis, anti-tumor activity, and docking studies of novel combretastatin analogs.
Rita Fürst
,
Christina Nowikow
,
Agnes Berenyi
,
Gerhard Ecker
,
Istvan Zupko
,
Uwe Rinner
239th ACS National Meeting
Conference,
Poster presentation
..2010 - ..2010
Tricyclic antidepressants competitively inhibit the serotonin transporter via an interaction involving two discontinuous binding sites.
Subhodeep Sarker
,
Rene Weissensteiner
,
Ilka M. Steiner
,
Harald H. Sitte
,
Gerhard Ecker
,
Michael Freissmuth
,
Sonja Sucic
3rd SFB35 Symposium 2010
Conference,
Poster presentation
..2010 - ..2010
In silico studies for prediction of substrates and inhibitors of P-glycoprotein.
Gerhard Ecker
Talk or oral contribution
1.9.2009 - 1.9.2009
2D- and 3D-similarity based classification systems for substrate prediction of ABCB1
Rita Schwaha
,
Gerhard Ecker
238th American Chemical Society National Meeting & Exposition
Conference,
Poster presentation
18.8.2009 - 18.8.2009